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DDiscussion
Dr Jennifer Sue Lawton (St Louis, Mo). Congratulations on
very nice, very useful work and a very nice presentation. I really
enjoyed your algorithm and the specificity for the different types
of valve pathology. As you know, we do not know the incidence
of significant CAD in the general population, and the study you
quoted from the New England Journal of Medicine by Patel et
al—they did not include valve surgery patients, and they used
different criteria for significant CAD. Your criterion was greater
than 50% stenosis in an epicardial vessel and theirs was 70% or
50% in the left main. They reported on 400,000 patients, approxi-
mately, about one third of whom were asymptomatic but had
disease, but for some reason those patients had undergone cardiac
catheterization. Similarly, in the 2008 updates of the American
Heart Association guidelines, they state that in an asymptomatic
population, the incidence is approximately 4%. So, with that in
mind, looking at your stratification of your study population, 752
patients were ruled out fairly soon if they had not undergone
preoperative catheterization within 6 months of the valve surgery.
Thus, for those patients, I have a question, if you have the data,
about them, because in your report you did mention that a few of
them had had MI or PCI before valve surgery. So, did they not un-
dergo cardiac catheterization before surgery by surgeon preference
or were they young patients with mitral regurgitation? If you have
any data on those patients, because, with that in mind, your estima-
tion of risk and your conclusions might have been underestimated
or overestimated. That is my first question.
Dr Thalji. Thank you very much for your comments, Dr Law-
ton, and for your very insightful question. You raise an important
point. Specifically, that a subset of patients that was excluded,
owing to the absence of preoperative angiography within 6 months
of surgery, did indeed have symptoms of angina, previous PCI, or
previous MI. There are several potential explanations for this.
First, we defined preoperative angiography as being within 6
months of the index surgery. Some patients had undergone preop-
erative angiography that was performed beyond this period; for
instance, within 6 months to 1 year. However, after consultation
with the cardiologists and cardiac surgeons, angiography
performed more than 6 months before surgery were deemed less
likely to be representative of the baseline burden of CAD.
Furthermore, it is also worthwhile noting that about 20% of the
patients who did not undergo conventional invasive angiography
did alternatively undergo computed tomography coronary angiog-
raphy. Most of these patients were those undergoing robotic mitral
valve repair, which, at our institution, is performed by Drs RakeshThe Journal of Thoracic and CarSuri and Harold Burkhart. It is standard practice at our institution
for all patients who undergo robotic cardiac surgery to undergo
computed tomography of the chest, abdomen, and pelvis to assess
for underlying vascular disease, including coronary stenosis. It is,
therefore, possible that these patients who had had MI, PCI, or
angina had been assessed by a computed tomographic angiogram,
which proved to be negative, hence circumventing the need for
conventional angiography.
Dr Lawton. Do you have data for those 752 patients and
whether any of them did undergo concomitant CABG with valve
surgery?
Dr Thalji. That is a good question. Yes, that is correct. Appro-
ximately 25 patients without angiography within 6 months of
surgery did require concomitant CABG. The situation for these
patients, as before, was such that the surgeons believed that
CCA more than 6 months before surgery was sufficient to guide
surgical practice and perform concomitant CABG. This highlights
that our algorithms are simply guides and do not outweigh the
sound clinical judgment of the surgeon.
Dr Lawton.My next question is, sort of as a devil’s advocate, a
number of surgeons are cautious and very conservative; thus,
how would you convince such surgeons to forego cardiac cathete-
rization preoperatively whenwe know additional data can be gained
from the study? It often provides a very nice look at the ascending
aorta and an assessment of left ventricular function. Additional find-
ings could be that that the patient has anomalous coronary anatomy,
such as a double-barrel left main, which could become important,
depending on your cardioplegia strategy. Similarly, if the patient is
right dominant and you plan a very long mitral repair, perhaps that
will not work and requires a replacement and you have only given
retrograde cardioplegia. A number of scenarios are possible, so
how could you convince us we do not need that information?
Dr Thalji. That is a great question, and there are several points
to be made. First, with the pending approval of the Affordable Care
Act, wewill all be called on to scrutinize our actions and assess the
associated costs. Our current investigation is the first step of
multiple studies that are forthcoming to determine whether we
are overusing coronary angiography. However, are we suggesting
that surgeons should abandon angiography altogether? No, we do
not believe this should be the case. What we are suggesting is that
perhaps subsets of patients who specifically are at a low risk of
CAD might be able to either forego invasive angiography or,
alternatively, undergo other less-invasive investigative procedures
to evaluate coronary obstruction. For instance, ventricular function
can potentially be assessed using echocardiography. To delineate
the coronary anatomy, computed tomography coronary angiog-
raphy has become a very popular topic examined in contemporary
studies. I think it is going to take a bit of time before we see a
marked shift in investigative habits; however, we need to start
being self-critical of our clinical practice and to evaluate the effect
it has on patient safety and on healthcare economics.
Dr David C. McGiffin (Birmingham, Ala). Has there been any
change at the clinic since this information, and if so, what do you
do now?
Dr Thalji. To date, what we can say is that there has been a
change in our mind sets. Specifically, we have come to appreciate
that a large divide exists between what we are currently doing and
perhaps what we should be doing. Importantly, validation of our
models in external populations is a critical and necessary stepdiovascular Surgery c Volume 146, Number 5 1063
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Dthat needs to be undertaken before we should drastically alter our
clinical practice.
Dr McGiffin. So it has not translated into a change yet?
Dr Thalji. To date, it has not.
Dr Shyam Kolvekar (London, United Kingdom). I enjoyed
your report, and I think your risks come with these problems.
I have 2 small questions. One, did you prefer stress echocardiog-
raphy compared to computed tomography angiography to find
the patients who do not have a high risk and to determine
whether they have any obstructive disease, because it is less inva-
sive? The second question is, did you have any complications
with your angiography patients where they had morbidity or
mortality?
Dr Thalji. Thank you for your questions. Regarding your first
question, you are correct, the published data have shown that stress
echocardiography can be leveraged to obtain valuable information
regarding the coronary disease burden. Although stress echocar-
diography is a less-invasive option, as a general rule of thumb,
clinicians have tended to have a greater peace of mind when
the coronary anatomy has been visualized, such as is the case
with angiography. These are certainly factors that merit consider-
ation when determining which preoperative investigations to
perform.
Regarding your second question, in terms of complications, we
do not have that data available for our population at the moment.1064 The Journal of Thoracic and Cardiovascular SurHowever, we can allude to previously published data detailing
that the rate of major complications at invasive angiography is
approximately 2%. However, as I said, we do not have that data
for our patients specifically.
Dr Rakesh M. Suri (Rochester, Minn). Just to comment on
Nassir’s very thoughtful answer and to respond to 1 of the last
questions. This is a large, retrospective population-based study,
and it was not designed to answer the specific question—if
coronary angiography is avoided, which surrogate tests or which
replacement tests should be ordered instead—that is a topic that
will be addressed in forthcoming investigations. We will be better
prepared to answer that as we move forward.
Dr A. Pieter Kappetein (Rotterdam, The Netherlands). Did
you consider the type of valvular heart disease, whether that
made a difference, whether it was stenotic, aortic valve disease,
or insufficiency?
Dr Thalji. That is a good question. We have not presented
such data. Nevertheless, in a subset analysis, we found that
aortic stenosis was an important variable predictive of underly-
ing significant CAD. Similarly, and as we have documented in
our study, patients undergoing AVS—the vast majority of
whom had aortic stenosis—(1) were more likely to have
coexistent CAD, and (2) were found to have coronary stenosis
at a much younger age compared with those undergoing MVS
or SM.gery c November 2013
